Skip to main content
Log in

Guideline versus non-guideline based management of rectal cancer in octogenarians

  • Research Paper
  • Published:
European Geriatric Medicine Aims and scope Submit manuscript

Abstract

Purpose

The number of octogenarians with rectal adenocarcinoma is growing. Current guidelines seem difficult to apply on octogenarians which may result in non-adherence. The aim of this retrospective cohort study is to give insight in occurrence of treatment-related complications, hospitalisations and survival among octogenarians treated according to guidelines versus octogenarians treated otherwise.

Methods

108 octogenarians with rectal adenocarcinoma were identified by screening of medical records. 22 patients were excluded for treatment process analysis because of stage IV disease or unknown stage. Baseline characteristics, diagnostic process, received treatment, motivation for deviation from guidelines, complications, hospitalisations and date of death were documented. Patients were divided in two groups depending on adherence to treatment guidelines. Differences in baseline characteristics, treatment-related complications and survival between both groups were evaluated.

Results

Diagnosis and treatment according to guidelines occurred in 95 and 54% of the patients, respectively. When documented, patient’s preference and comorbidities were major reasons to deviate from guidelines. 66% of patients who were treated according to guidelines experienced complications versus 34% of those treated otherwise (p = 0.02). After adjustment for differences in age and polypharmacy, this association was not significant. Patients treated according to the guideline had better survival 18 months after diagnosis (80 versus 56%, p = 0.02).

Conclusions

Treating octogenarians with rectal cancer according to guidelines seem to lead to better overall survival, but may lead to a high risk of complications. This may jeopardise quality of life. More and prospective studies in octogenarians with rectal cancer are needed to customize guidelines for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dutch cancer registration, by IKNL. http://www.cijfersoverkanker.nl/. Accessed 01 Feb 2017

  2. Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 3(4):524–548

    Article  Google Scholar 

  3. SEER Cancer Stat Facts: Colorectal Cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/colorect.html. Accessed 19 Apr 2018

  4. de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE et al (2013) Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev 22(4):561–570

    Article  Google Scholar 

  5. Vincent GK, Velkoff VA (2010) The next four decades, the older population in the United States: 2010 to 2050. Current Population Reports, US Census Bureau, Washington, DC, pp P25–P1138

  6. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067

    Article  PubMed  CAS  Google Scholar 

  7. Schiphorst AH, Verweij NM, Pronk A, Hamaker ME (2014) Age-related guideline adherence and outcome in low rectal cancer. Dis Colon Rectum 57(8):967–975

    Article  PubMed  Google Scholar 

  8. Maas HAAM, Lemmens VEPP, Nijhuis PHA, de Hingh IHJT, Koning CCE, de Janssen-Heijnen MLG (2013) Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older. EJSO 39:1087–1093

    Article  PubMed  CAS  Google Scholar 

  9. Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML (2006) Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 42(17):3015–3021

    Article  PubMed  CAS  Google Scholar 

  10. Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL (2016) Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment. J Cancer Res Clin Oncol 142(3):699–706

    Article  PubMed  CAS  Google Scholar 

  11. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  PubMed  CAS  Google Scholar 

  12. Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251

    Article  PubMed  CAS  Google Scholar 

  13. Integraal kankercentrum Nederland (IKNL) (2008) Rectumcarcinoom. Landelijke richtlijn met regionale toevoegingen, Versie: 2.1, accepted on 09.01.2008. www.oncoline.nl (Dutch guideline for rectalcarcinoma)

  14. Integraal kankercentrum Nederland (IKNL) (2014) Colorectaalcarcinoom. Landelijke richtlijn, Versie: 3.0, accepted on 16.04.2014. www.oncoline.nl (Dutch guideline for colorectal carcinoma)

  15. Lemmens VE, Verheij CD, Janssen-Heijnen ML, Rutten HJ, Coebergh JW, Gastro-Intestinal Cancer Study Group Comprehensive Cancer Centre South Ikz ETN (2006) Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. Eur J Surg Oncol 32(2):168–173

    Article  PubMed  CAS  Google Scholar 

  16. van der Geest LG, Krijnen P, Wouters MW, Erkelens WG, Marinelli AW, Nortier HJ et al (2012) Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands. J Surg Oncol 106(1):1–9

    Article  PubMed  Google Scholar 

  17. Rayson D, Urquhart R, Cox M, Grunfeld E, Porter G (2012) Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis. J Oncol Pract 8(4):253–259

    Article  PubMed  PubMed Central  Google Scholar 

  18. Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ (2012) Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer 118(13):3345–3355

    Article  PubMed  Google Scholar 

  19. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y et al (2013) Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 119(8):1593–1601

    Article  PubMed  Google Scholar 

  20. Hines RB, Barrett A, Twumasi-Ankrah P, Broccoli D, Engelman KK, Baranda J et al (2015) Predictors of guideline treatment nonadherence and the impact on survival in patients with colorectal cancer. J Natl Compr Cancer Netw 13(1):51–60

    Article  Google Scholar 

  21. Dekker JW, Gooiker GA, Bastiaannet E, van den Broek CB, van der Geest LG, van de Velde CJ et al (2014) Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients. Eur J Surg Oncol 40(11):1481–1487

    Article  PubMed  CAS  Google Scholar 

  22. van der Sluis FJ, Buisman PL, Meerdink M, Aan de Stegge WB, van Etten B, de Bock GH et al (2017) Risk factors for postoperative delirium after colorectal operation. Surgery 161(3):704–711

    Article  PubMed  Google Scholar 

  23. Liu L, Wang T, Zhang G, Dai R, Liang H, Tang L (2016) Risk factors for early complications after laparoscopic total mesorectal excision for locally advanced rectal cancer: a single center experience. J Cancer Res Ther 12(1):350–354

    Article  PubMed  CAS  Google Scholar 

  24. Tan KY, Chen CM, Ng C, Tan SM, Tay KH (2006) Which octogenarians do poorly after major open abdominal surgery in our Asian population? World J Surg 30(4):547–552

    Article  PubMed  Google Scholar 

  25. Woopen H, Richter R, Ismaeel F, Chekerov R, Roots I, Siepmann T et al (2016) The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer. Gynecol Oncol 140(3):554–558

    Article  PubMed  CAS  Google Scholar 

  26. Picker D, Heard K, Bailey TC, Martin NR, LaRossa GN, Kollef MH (2015) The number of discharge medications predicts thirty-day hospital readmission: a cohort study. BMC Health Serv Res 15:282

    Article  PubMed  PubMed Central  Google Scholar 

  27. Maggiore RJ, Dale W, Gross CP, Feng T, Tew WP, Mohile SG et al (2014) Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc 62(8):1505–1512

    Article  PubMed  PubMed Central  Google Scholar 

  28. Park JW, Roh JL, Lee SW, Kim SB, Choi SH, Nam SY et al (2016) Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer. J Cancer Res Clin Oncol 142(5):1031–1040

    Article  PubMed  CAS  Google Scholar 

  29. Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D et al (2015) Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol 26(3):463–476

    Article  PubMed  CAS  Google Scholar 

  30. Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32(24):2595–2603

    Article  PubMed  PubMed Central  Google Scholar 

  31. Schulkes KJ, Souwer ET, Hamaker ME, Codrington H, van der Sar-van der Brugge S, Lammers JJ et al (2017) The effect of A geriatric assessment on treatment decisions for patients with lung cancer. Lung 195(2):225–231

    Article  PubMed  PubMed Central  Google Scholar 

  32. Verweij NM, Souwer ETD, Schiphorst AHW, Maas HA, Portielje JEA, Pronk A et al (2017) The effect of a geriatric evaluation on treatment decisions for older patients with colorectal cancer. Int J Colorectal Dis 32(11):1625–1629

    Article  PubMed  CAS  Google Scholar 

  33. Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC (2012) The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 17(11):1439–1449

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept: FB, AV. Study design: FB, AV, MLJ-H. Data acquisition: AV, LV. Quality control of data and algorithms: AV, MLJ-H. Data analysis and interpretation: AV, FB, YW, EB, FJV, MLJ-H. Statistical analysis: AV, MLJ-H. Manuscript preparation: AV, FB, YW, MLJ-H. Manuscript editing: AV, FB, YW, EB, FJV, MLJ-H. Manuscript review: AV, FB, YW, EB, FJV, MLJ-H.

Corresponding author

Correspondence to F. van den Berkmortel.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Vuuren, A., Verhoeven, L., van den Berkmortel, F. et al. Guideline versus non-guideline based management of rectal cancer in octogenarians. Eur Geriatr Med 9, 533–541 (2018). https://doi.org/10.1007/s41999-018-0070-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41999-018-0070-2

Keywords

Navigation